From the Merck Manual
A recent study that was presented at the 2015 American Academy of Neurology provided data about a drug
that may ultimately be useful for multiple sclerosis. Unlike existing drugs used in MS, which reduce inflammation, this new drug, a monoclonal antibody to LINGO-1, is designed to repair myelin.
Michael C. Levin, MD Professor of Neurology, University of Tennessee Health CenterMore